Evidence map›Paper›PMID 31097414›Full record

Trial reportThe Lancet. Global health2019

Effect of a stepped-care intervention delivered by lay health workers on major depressive disorder among primary care patients in Nigeria (STEPCARE): a cluster-randomised controlled trial.

Oye Gureje, Bibilola D Oladeji, Alan A Montgomery, Toyin Bello, Lola Kola, Akin Ojagbemi, Dan Chisholm, Ricardo Araya

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Lancet. Global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Neuropsychiatry genetics in Africa.Nature communications · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Oye GurejeDepartment of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria. Electronic address: ogureje@comui.edu.ng.
Bibilola D OladejiDepartment of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Alan A MontgomeryNottingham Clinical Trials Unit, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
Toyin BelloDepartment of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Lola KolaDepartment of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Akin OjagbemiDepartment of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Dan ChisholmDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Ricardo ArayaDepartment of Health Services and Population Research, King's College London, London, UK.
University of Ibadan · NGKing's College London · GBUniversity of Nottingham · GBWorld Health Organization · CH

Funding

Medical Research Council MR/K00753X/1World Health Organization 001
6 · The paper itself

Abstract

backgroundLittle is known about how to scale up care for depression in settings where non-physician lay workers constitute the bulk of frontline providers. We aimed to compare a stepped-care intervention package for depression with usual care enhanced by use of the WHO Mental Health Gap Action Programme intervention guide (mhGAP-IG).

methodsWe did a cluster-randomised trial in primary care clinics in Ibadan, Nigeria. Eligible clinics were those with adequate staffing to provide various 24-h clinical services and with regular physician supervision. Clinics (clusters), anonymised and stratified by local government area, were randomly allocated (1:1) with a computer-generated random number sequence to one of two groups: an intervention group in which patients received a stepped-care intervention (eight sessions of individual problem-solving therapy, with an extra two to four sessions if needed) plus enhanced usual care, and a control group in which patients received enhanced usual care only. Patients from enrolled clinics could participate if they were aged 18 years or older, not pregnant, and had moderate to severe depression (scoring ≥11 on the nine-item patient health questionnaire [PHQ-9]). The primary outcome was the proportion of patients with remission of depression at 12 months (a score of ≤6 on the PHQ-9, with assessors masked to group allocation) in the intention-to-treat population. This trial is registered with the International Standard Randomised Controlled Trials Number registry (ISRCTN46754188) and is completed.

findings35 of 97 clinics approached were eligible and agreed to participate, of which 18 were allocated to the intervention group and 17 to the control group. 1178 patients (631 [54%] in the intervention group and 547 [46%] in the control group) were recruited between Dec 2, 2013, and June 29, 2015, among whom 976 (83%) were female and baseline mean PHQ-9 score was 13·7 (SD 2·6). Of the 562 (89%) patients in the intervention group and 473 (86%) in the control group who completed 12-month follow-up, similar proportions in each group had remission of depression (425 [76%] in the intervention group vs 366 [77%] in the control group; adjusted odds ratio 1·0 [95% CI 0·70-1·40]). At 12 months, 17 (3%) deaths, one (<1%) psychotic illness, and one (<1%) case of bipolar disorder in the intervention group, and 16 deaths (3%) and one (<1%) case of bipolar disorder in the control group were recorded. No adverse events were judged to be related to the study procedures.

interpretationFor patients with moderate to severe depression receiving care from non-physician primary health-care workers in Nigeria, a stepped-care, problem-solving intervention combined with enhanced usual care is similarly effective to enhanced usual care alone. Enhancing usual care with mhGAP-IG might provide simple and affordable approach to scaling up depression care in sub-Saharan Africa.

fundingUK Medical Research Council.

Indexed as

Allied Health PersonnelPrimary Health CareAdultAgedCluster AnalysisCost-Benefit AnalysisDelivery of Health CareFemaleHumansMajor Depressive DisorderMaleMiddle AgedNigeriaTreatment Outcome

Identifiers

PMID31097414
PMCPMC6559947
OpenAlexW2946704922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.